Analysis of measurable residual disease by IG/TR gene rearrangements: quality assurance and updated EuroMRD guidelines.
van der Velden VHJ, Dombrink I, Alten J, Cazzaniga G, Clappier E, Drandi D, Eckert C, Fronkova E, Hancock J, Kotrova M, Kraemer R, Montonen M, Pfeifer H, Pott C, Raff T, Trautmann H, Cavé H, Schäfer BW, van Dongen JJM, Trka J, Brüggemann M; EuroMRD Consortium.
van der Velden VHJ, et al. Among authors: hancock j.
Leukemia. 2024 May 14. doi: 10.1038/s41375-024-02272-0. Online ahead of print.
Leukemia. 2024.
PMID: 38744919